Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, July 1998, p. 1587-1591, Vol. 42, No. 7
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Inhibition of Hyphal Growth of Azole-Resistant
Strains of Candida albicans by Triazole Antifungal Agents
in the Presence of Lactoferrin-Related Compounds
Hiroyuki
Wakabayashi,1,*
Shigeru
Abe,2
Susumu
Teraguchi,1
Hirotoshi
Hayasawa,1 and
Hideyo
Yamaguchi2
Nutritional Science Laboratory, Morinaga Milk
Industry Co., Ltd., Zama, Kanagawa
228-8583,1 and
Department of
Microbiology and Immunology, Teikyo University School of Medicine,
Itabashi-ku, Tokyo 173-8605,2 Japan
Received 8 September 1997/Returned for modification 27 January
1998/Accepted 13 April 1998
The effects of bovine lactoferrin (LF) or the LF-derived
antimicrobial peptide lactoferricin B (LFcin B) on the growth of Candida albicans hyphae, including those of three
azole-resistant strains, were investigated by a crystal violet staining
method. The hyphae of two highly azole-resistant strains were more
susceptible to inhibition by LF or LFcin B than the
azole-susceptible strains tested. One moderately azole-resistant strain
was defective in the formation of hyphae and showed a susceptibility to
LF greater than that of the susceptible strains but a susceptibility to
LFcin B similar to that of the susceptible strains. The highly
azole-resistant strain TIMM3317 showed trailing growth in the presence
of fluconazole or itraconazole, while the extent of growth was reduced
by the addition of LF or LFcin B at a sub-MIC. Thus, the addition
of LF or LFcin B at a sub-MIC resulted in a substantial decrease in the
MICs of fluconazole and itraconazole for two highly
azole-resistant strains; e.g., the MIC of fluconazole for TIMM3317
was shifted from >256 to 0.25 µg/ml by LF, but the MICs were not
decreased for the susceptible strains. The combination effects observed with triazoles and LF-related compounds in the case of the two highly
azole-resistant strains were confirmed to be synergistic by the
fractional inhibitory concentration index. These results demonstrate
that for some azole-resistant C. albicans strains, LF-related compounds combined with triazoles can inhibit the growth of
hyphae, an important form of this organism in pathogenesis.
*
Corresponding author. Mailing address: Nutritional
Science Laboratory, Morinaga Milk Industry Co., Ltd., 5-1-83 Higashihara, Zama, Kanagawa 228-8583, Japan. Phone: 81-462-52-3045. Fax: 81-462-52-3049.
Antimicrobial Agents and Chemotherapy, July 1998, p. 1587-1591, Vol. 42, No. 7
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Kitamura, A., Higuchi, S., Hata, M., Kawakami, K., Yoshida, K., Namba, K., Nakajima, R.
(2009). Effect of {beta}-1,6-Glucan Inhibitors on the Invasion Process of Candida albicans: Potential Mechanism of Their In Vivo Efficacy. Antimicrob. Agents Chemother.
53: 3963-3971
[Abstract]
[Full Text]
-
Wakabayashi, H., Yamauchi, K., Kobayashi, T., Yaeshima, T., Iwatsuki, K., Yoshie, H.
(2009). Inhibitory Effects of Lactoferrin on Growth and Biofilm Formation of Porphyromonas gingivalis and Prevotella intermedia. Antimicrob. Agents Chemother.
53: 3308-3316
[Abstract]
[Full Text]
-
Noverr, M. C., Huffnagle, G. B.
(2004). Regulation of Candida albicans Morphogenesis by Fatty Acid Metabolites. Infect. Immun.
72: 6206-6210
[Abstract]
[Full Text]
-
Takakura, N., Wakabayashi, H., Ishibashi, H., Yamauchi, K., Teraguchi, S., Tamura, Y., Yamaguchi, H., Abe, S.
(2004). Effect of orally administered bovine lactoferrin on the immune response in the oral candidiasis murine model. J Med Microbiol
53: 495-500
[Abstract]
[Full Text]
-
Takakura, N., Wakabayashi, H., Ishibashi, H., Teraguchi, S., Tamura, Y., Yamaguchi, H., Abe, S.
(2003). Oral Lactoferrin Treatment of Experimental Oral Candidiasis in Mice. Antimicrob. Agents Chemother.
47: 2619-2623
[Abstract]
[Full Text]
-
Lupetti, A., Paulusma-Annema, A., Welling, M. M., Dogterom-Ballering, H., Brouwer, C. P. J. M., Senesi, S., van Dissel, J. T., Nibbering, P. H.
(2003). Synergistic Activity of the N-Terminal Peptide of Human Lactoferrin and Fluconazole against Candida Species. Antimicrob. Agents Chemother.
47: 262-267
[Abstract]
[Full Text]
-
Wakabayashi, H., Uchida, K., Yamauchi, K., Teraguchi, S., Hayasawa, H., Yamaguchi, H.
(2000). Lactoferrin given in food facilitates dermatophytosis cure in guinea pig models. J Antimicrob Chemother
46: 595-602
[Abstract]
[Full Text]
-
McLain, N., Ascanio, R., Baker, C., Strohaver, R. A., Dolan, J. W.
(2000). Undecylenic Acid Inhibits Morphogenesis of Candida albicans. Antimicrob. Agents Chemother.
44: 2873-2875
[Abstract]
[Full Text]
-
Oh, H., Hedberg, M., Wade, D., Edlund, C.
(2000). Activities of Synthetic Hybrid Peptides against Anaerobic Bacteria: Aspects of Methodology and Stability. Antimicrob. Agents Chemother.
44: 68-72
[Abstract]
[Full Text]
-
Heinig, M. J., Francis, J., Pappagianis, D.
(1999). Mammary Candidosis in Lactating Women. J Hum Lact
15: 281-288
[Abstract]
-
Kuipers, M. E., de Vries, H. G., Eikelboom, M. C., Meijer, D. K. F., Swart, P. J.
(1999). Synergistic Fungistatic Effects of Lactoferrin in Combination with Antifungal Drugs against Clinical Candida Isolates. Antimicrob. Agents Chemother.
43: 2635-2641
[Abstract]
[Full Text]
-
Wakabayashi, H., Matsumoto, H., Hashimoto, K., Teraguchi, S., Takase, M., Hayasawa, H.
(1999). N-Acylated and D Enantiomer Derivatives of a Nonamer Core Peptide of Lactoferricin B Showing Improved Antimicrobial Activity. Antimicrob. Agents Chemother.
43: 1267-1269
[Abstract]
[Full Text]
-
Ha, K. C., White, T. C.
(1999). Effects of Azole Antifungal Drugs on the Transition from Yeast Cells to Hyphae in Susceptible and Resistant Isolates of the Pathogenic Yeast Candida albicans. Antimicrob. Agents Chemother.
43: 763-768
[Abstract]
[Full Text]